Isoniazid Tablets Shortage
Last Updated: March 3, 2025
Status: Current
Products Affected - Description
-
- Isoniazid oral tablet, Mylan (Viatris), 300 mg, unit-dose blister pack, 100 count, NDC 51079-0083-20
- Isoniazid oral tablet, Teva, 100 mg, bottle, 100 count, NDC 00555-0066-02 - discontinued
- Isoniazid oral tablet, Teva, 300 mg, bottle, 30 count, NDC 00555-0071-01 - discontinued
- Isoniazid oral tablet, Teva, 300 mg, bottle, 100 count, NDC 00555-0071-02 - discontinued
Reason for the Shortage
-
- Genus Lifesciences launched isoniazid in late-2024.
- Teva divested isoniazid tablets to Genus Lifesciences in late-2024.
- Viatris did not provide a reason for the shortage.
Available Products
-
- Isoniazid oral tablet, Genus Lifesciences, 100 mg, bottle, 100 count, NDC 64950-0216-10
- Isoniazid oral tablet, Genus Lifesciences, 300 mg, bottle, 30 count, NDC 64950-0217-03
- Isoniazid oral tablet, Genus Lifesciences, 300 mg, bottle, 100 count, NDC 64950-0217-10
Estimated Resupply Dates
-
- Viatris has isoniazid 300 mg tablets in 100 count unit-dose packages on back order and the company cannot estimate a release date.
Updated
Updated March 3, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 1, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.